Biosimilars: What Can Retina Learn from Oncology?

Related

• 

  Open-Label Study Evaluating the Effects of the CCR3 Antagonist ALK4290 in Patients With Neovascular AMD Refractory to Anti-VEGF Therapy

  Michael W. Stewart, MD

  Annual Meeting Talks

  2019

• 

  Clinical Experience With the SCS Microinjector for Suprachoroidal Injections by Ophthalmologists

  Milan Shah, MD

  Annual Meeting Talks

  2019

• 

  Ethics in Retina: A Discussion on the Ethical Considerations in Industry Relationships and Informed Consent

  Nancy M. Holekamp, MD, FASRS

  J. Michael Jumper, MD, FASRS

  Paul Chan

  Adrienne W. Scott, MD, FASRS

  Webinars and Journal Clubs

  2017